Next Article in Journal
Assessing Cardiovascular Risk with Coronary Artery Calcium and Carotid Intima-Media Thickness in Patients with Negative Stress Echocardiography
Next Article in Special Issue
Investigating the Epigenetic Landscape of Major Depressive Disorder: A Genome-Wide Meta-Analysis of DNA Methylation Data, Including New Insights into Stochastic Epigenetic Mutations and Epivariations
Previous Article in Journal
Editorial to the Special Issue “Molecular and Cellular Mechanisms of CVD: Focus on Atherosclerosis”
Previous Article in Special Issue
The Humoral Immune Response against Human Endogenous Retroviruses in Celiac Disease: A Case–Control Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dopamine and Serotonin Transporter Genes Regulation in Highly Sensitive Individuals during Stressful Conditions: A Focus on Genetics and Epigenetics

1
Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo, Italy
2
Department of Innovative Technologies in Medicine and Dentistry, University “G. D’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
3
Center for Advanced Studies and Technology (CAST), University “G. D’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
4
Department of Social Sciences, University of Foggia, 71122 Foggia, Italy
5
Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy
6
Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, 20019 Milan, Italy
7
“Aldo Ravelli” Center for Nanotechnology and Neurostimulation, University of Milan, 20122 Milan, Italy
8
Center for Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy
9
Department of Psychological, Health and Territorial Sciences, University “G. D’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
10
Department of Neuroscience, Imaging and Clinical Sciences, University “G.D’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
11
Department of Clinical Neuroscience, Karolinska Institute, 10316 Stockholm, Sweden
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(9), 2149; https://doi.org/10.3390/biomedicines12092149
Submission received: 14 August 2024 / Revised: 9 September 2024 / Accepted: 17 September 2024 / Published: 23 September 2024
(This article belongs to the Special Issue Epigenetic Regulation and Its Impact for Medicine)

Abstract

:
Background: Coping with stress is essential for mental well-being and can be critical for highly sensitive individuals, characterized by a deeper perception and processing of stimuli. So far, the molecular bases characterizing high-sensitivity traits have not been completely investigated and gene × environment interactions might play a key role in making some people more susceptible than others. Methods: In this study, 104 young adult university students, subjects that might face overwhelming experiences more than others, were evaluated for the genetics and epigenetics of dopamine (DAT1) and serotonin (SERT) transporter genes, in addition to the expression of miR-132, miR-491, miR-16, and miR-135. Results: We found an increase in DNA methylation at one specific CpG site at DAT1 5’UTR in highly sensitive students reporting high levels of perceived stress when compared to those less sensitive and/or less stressed. Moreover, considering DAT1 VNTR at 3’UTR, we observed that this effect was even more pronounced in university students having the 9/9 genotype when compared to those with the 9/10 genotype. These data are corroborated by the higher levels of miR-491, targeting DAT1, in highly sensitive subjects with high levels of perceived stress. SERT gene DNA methylation at one specific CpG site was reported to instead be higher in subjects reporting lower perceived stress when compared to more stressed subjects. Consistently, miR-135 expression, regulating SERT, was lower in subjects with higher perceived stress. Conclusions: We here suggest that the correlation of DAT1 and SERT genetic and epigenetic data with the analysis of stress and sensitivity might be useful to suggest possible biomarkers to monitor mental health wellness in vulnerable subjects.

1. Introduction

Physiological and psychological challenges occur in life transition periods like late adolescence and young adulthood [1,2,3,4,5,6,7,8,9,10,11,12], during which coping with stress is necessary and natural. This is particularly true for university students since several environmental triggers, such as academic overload, insufficient organization of time, competitiveness, financial concerns, and familial pressures, produce stressful situations [13] that might alter mental health and well-being [14,15,16,17]. Indeed, several mental health disorders happen to start during this period [16,17,18,19,20].
The perception of stress varies among students [21] and the possible development of a mental health issue and/or a decrease in well-being might occur more likely in individuals with high sensitivity [22,23]. Highly sensitive individuals possess a keen awareness of their surroundings [24], become easily overwhelmed by an emotionally charged environment [25,26], and are therefore more susceptible to perceived stress [27]. From a biological perspective, a clear understanding of what induces a high sensitivity remains elusive [28]. Among others, genetic variations affecting serotonergic or dopaminergic systems have been reported to be relevant in subjects reporting environmental adversity stress contributing to high sensitivity [29,30,31]. It is worth mentioning the serotonin transporter-linked promoter region (5-HTTLPR) polymorphism, characterized by a variable number of tandem repeats (44-basepair insertion/deletion) in the serotonin transporter (SERT) gene promoter region, giving rise to a long (L) and short (S) allele. Numerous meta-analyses revealed a consistent relationship between a genetic susceptibility to anxiety and the polymorphism of the serotonin transporter gene [32,33,34,35]. In particular, the S allele is associated with anxiety-related traits [36] and, of relevance in the frame of this report, to neuroticism-related traits in a healthy population [37]. On the other hand, the L allele has been associated with increased anxiety in subjects during stressful life events [38]. Another relevant polymorphism located in the dopamine transporter (DAT1) gene at the 3′-untranslated region (UTR) has been associated with anxiety and stress [39,40]. It consists of a variable number of tandem repeats (VNTR) repeated between 3 and 13 times, with the 9- and 10-repeat alleles being the most frequent. Researchers have deeply investigated this VNTR in personality trait variation [41].
However, for these polymorphisms, as well as for many others, results are not consistent across studies, and most molecular genetic studies focusing on specific human traits generally account for less than 1% of individual variance [42]. This lack of reproducible findings is due to many factors, such as subjects’ different compositions (size, ethnicity, age, gender) and differences in the measures of behavioral outcomes. It should also be considered that it is very likely that complex traits, such as personality, might be polygenic, and it is of relevance to evaluate the possible effects of the combination of multiple gene loci [43,44]. Moreover, environmental factors could have a role in the development of a specific phenotype interacting with the genotype [45,46] or beside the genotype [47,48,49]. It is thus important to account for epigenetics, which involves all those marks that, without changing the DNA code, can alter the physical structure of the genome and, in turn, activate or inactivate genes [47].
Considering this background, the present study seeks to identify the risk factors that make university students more susceptible to developing mental health issues by examining if individual differences in sensory-processing sensitivity and perceived stress can be associated with differences in the genetic and epigenetics of DAT1 and SERT genes. For assessing sensitivity, we referred to the phenotypical trait of sensory-processing sensitivity. This trait is different from other commonly assessed personality and temperament traits, and it helps predict how individuals respond to environmental stimuli [24,50]. For the molecular analysis, we obtained genomic DNA and exosomal circulating microRNAs (miRNAs) from non-stressful and easily accessible samples of saliva, already used to conduct genetic as well as epigenetic studies, specifically, DNA methylation [51] and miRNA expression [52,53] studies. Moreover, changes in DNA methylation in saliva have been found to correlate with those in the brain [54] and blood [55].

2. Materials and Methods

2.1. Participants

A total of 104 subjects (mean age of 20.04 ± 1.77 years; 19 males and 85 females) were recruited on a voluntary basis through a public announcement disseminated across various university courses. Exclusion criteria included a prior diagnosis of a psychiatric disorder, previous or current use of medication for a psychiatric disorder, and past or present use of drugs or psychotropic substances. Written informed consent was provided by participants and they also did not receive credit compensation for their participation. The sample’s characteristics are reported in Table S1.

2.2. Procedure

Each participant completed an online survey (Qualtrics, Provo, UT, USA) that could be submitted just one time from an IP address. The survey included the Highly Sensitive Person (HSP) test and the Perceived Stress Scale (PSS) test as well as questions about demographic features (gender and age). Furthermore, to guarantee that participants were engaged throughout the survey process, a verification question was incorporated, prompting them to select a specific response. Questionnaires were completed independently rather than answering the operator to prevent interference in responding to the individual questions.

2.3. Behavioral Tests

2.3.1. The 12-Item HSP Scale

The Highly Sensitive Person (HSP) test is an instrument developed to evaluate the sensory-processing sensitivity of stimuli coming from the environment [24]. In this study, the Italian version of the test was used with a self-report of 12 items [23,50] assessed on a 7-point Likert scale (from 1 = strongly disagree to 7 = strongly agree). Example items are “Are you easily overwhelmed by strong sensory input?”, “Do other people’s mood affect you?”, and “Are you deeply moved by arts or music?”. The instrument is composed of three psychometric subscales: ease of excitation (items 4, 6, 8, 9, 12), which is being easily overwhelmed by stimuli both internal and external; esthetic sensitivity (items 1, 3, 5, 10), which is capturing esthetic awareness; and low sensory threshold (items 2, 7, 11), which is unpleasant sensory arousal to external stimuli [56]. In line with the bifactor model, HSP has a total score obtained by taking the average across all 12 items, with higher scores indicating higher levels of sensitivity [57]. For the current sample, the measure’s internal consistency was good (Cronbach’s α = 0.81).

2.3.2. Perceived Stress Scale (PSS-10)

The Perceived Stress Scale (PSS) is commonly used to measure stress levels [58]. In the current work, the Italian 10-item version of the scale was administered (PSS10) [59]. Respondents were asked to answer questions about their self-assessed psychological state during the last month using a five-point Likert scale (from never = 0 to very often = 4). An example of an item is, “How often have you been upset because of something that happened unexpectedly?”. The measure had good internal consistency in the present sample (Cronbach’s α = 0.79).

2.3.3. Interaction between HSP and PSS

We correlated data on sensitivity and perceived stress with the molecular ones and defined new cut-offs based on HSP × PSS interactions. Students were identified as follows: a “low cumulative risk” group considering their low/medium sensitivity and their low/moderate perceived stress (HSP<4 and PSS<26, together with HSP<4.5 and PSS<13); a “medium cumulative risk” group considering a medium interval of both the parameters and the combination between low sensitivity and high perceived stress (HSP<4 and PSS>27) or between high sensitivity and low perceived stress (HSP>4.5 and PSS<13); and a “high cumulative risk” group considering both the highest values for the two parameters (HSP>4.5 and PSS>27), or the combination between the high score of one parameter and the medium score of the other one (HSP>4.5 and 14<PSS<26; 4<HSP<4.5 and PSS>27). This subjects’ stratification was considered for DNA methylation analysis at DAT1 and SERT CpG sites and miRNAs expression.

2.4. Molecular Studies

2.4.1. Salivary Samples Collection

Participants self-collected saliva samples by spitting about 2 mL into collection tubes. To minimize contamination risks, they were asked to not eat, drink (water permitted), take medications, use lip products, smoke, or brush their teeth for at least two hours prior to sample collection. The samples were then stored at −80 °C until further processing.

2.4.2. DNA Extraction and Methylation Study

Genomic DNA was extracted by salting-out method [60] and assessed for quantity and quality using the NanoDrop 2000c UV-Vis Spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA). DNA was bisulfite converted using EZ DNA Methylation-GoldTM Kit (Zymo Research, Orange, CA, USA), and each CpG site DNA methylation status was assessed by pyrosequencing [see [61] for details]. The reliability of the results is guaranteed by built-in controls for the bisulfite treatment, which removes the need for manual calculation of non-converted DNA levels and prevents false-positive methylation detection, including an internal control for the bisulfite treatment in the analysis to examine the DNA methylation percentage in the individual CpG site [62]. The ROUT method was used to exclude values recognized as outliers. The primers used and the genomic location of the sequence analyzed are reported in Table 1.

2.4.3. Exosomal miRNAs Extraction and Real-Time PCR

Exosomal vesicles were isolated from saliva samples using Total Exosome Isolation Buffer (Invitrogen by Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s recommended protocol. Saliva samples were centrifuged at 2000× g at 4 °C for 10 min, 500 µL of supernatant was collected and 250 µL of total exosome isolation buffer was added. After a 1 h incubation at 4 °C, exosomes were precipitated by centrifugation at 10,000× g for 1 h. The supernatant was discarded, and samples were subjected to additional centrifugation at 10,000× g for 5 min to remove the residual solution. The exosomal RNA was extracted using TRIzol Reagent (Life Technologies, Ambion, Austin, TX, USA) and the miRNAs were reverse transcribed with the miRCURY LNA RT Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
The expression of miRNAs was measured by qRT-PCR on a DNA Engine Opticon 2 Continuous Fluorescence Detection System (MJ Research, Waltham, MA, USA) using SensiFAST™ SYBR Lo-ROX (Bioline—Meridian Bioscience, Tennessee, TN, USA) and specific primers (Qiagen, Hilden, Germany) (Table 2). We defined the relative amount of four miRNAs selected using the miRDB online database [63] for miRNA target prediction (two miRNAs targeting DAT1: miR-132 and miR-491; two miRNAs targeting SERT: miR-135 and miR-16-5p). Their expression was normalized using the ΔΔCt method (against the housekeeping miR-26a-5p and U6 snRNA) and then converted to the relative expression ratio (2−ΔΔCt).

2.4.4. SERT 5-HTTLPR and DAT1 VNTR Genotype

The following PCR primers were used for 5-HTTLPR genotyping: F: 5′-CGTTGCCGCTCTGAATGC-3′; R: 5′-TGGTAGGGTGCAAGGAGAATG-3′ [64]. Cycling conditions were as follows: 95 °C for 15 min, 94 °C for 30 s, 56 °C for 30 s, 72 °C for 30 s (45 cycles), and 72 °C for 10 min. A 2% agarose gel electrophoresis was used for the detection of PCR fragments visualized using Bio-Rad Gel Doc System: short allele, 340 bp; long allele, 384 bp.
The following PCR primers were used to detect the 40 bp VNTR in the 3′-untranslated region of the DAT1 gene: F: 5′-TGTGGTGTAGGGAACGGCCTGAG-3′; R: 5′-CTTCCTGGAGGTCACGGCTCAAGG-3′ [65]. PCR fragment lengths were 360 bp (7-repeat allele), 400 bp (8-repeat allele), 440 bp (9-repeat allele), and 480 bp (10-repeat allele). A schematic representation of the gene regions analyzed is reported in Figure 1.

2.4.5. Statistical Analysis

The data are expressed as mean ± standard error of the mean (SEM). Non-parametric One-way ANOVA was used to test the difference between the groups in the individual CpG site for DNA methylation analysis and to evaluate the difference in miRNAs expression between the three groups of subjects identified by their PSS, HSP, and HSP × PSS scores. Differences in individual CpG site methylation were analyzed using Dunn’s test without multiple comparisons since none of the groups that are part of the study sample can be identified as a control group. The correlation analysis between DNA methylation levels in the individual CpG sites or between the two psychometric factors was performed with Spearman’s correlation coefficient. The Hardy–Weinberg equilibrium for genotype analysis was assessed using the Chi-square test. Considering the arbitrary division of the subjects based on questionnaire scores, we compared the groups one to one using the Kruskal–Wallis with Uncorrected Dunn’s test. The p-values < 0.05 were considered statistically significant.

3. Results

3.1. Sample Characteristics

Subjects were divided into three groups on the basis of their score on the PSS test (low (PSS<13, N = 18), medium (14<PSS<26, N = 55), high (27<PSS, N = 31)), the HSP test (low (HSP<4, N = 10), medium (4<HSP<4.5, N = 21), high (4.5<HSP, N = 73)) or considering the interaction between HSP and PSS (low cumulative risk (low HSP with low PSS, low HSP with medium PSS, and medium HSP with low PSS, N = 17); medium cumulative risk (medium HSP with medium PSS, low HSP with high PSS, and high HSP with low PSS, N = 21); high cumulative risk (high HSP with high PSS, medium HSP with high PSS, and high HSP with medium PSS, N = 66)) (see Table S1).

3.2. DNA Methylation Studies

An increase in DNA methylation was observed at DAT1 gene CpG 1 (Chr5: 1444717) in the high perceived stress group when compared to the moderate perceived stress group (medium = 7.40 ± 0.32; high = 8.34 ± 0.35, p = 0.0254; Kruskal–Wallis, Uncorrected Dunn’s test). At DAT1 gene CpG 7 (Chr5: 1444685), higher DNA methylation levels were also observed in the moderate perceived stress group when compared to the high perceived stress group (medium = 11.79 ± 0.63; high = 9.92 ± 0.36, p = 0.0392) (Figure 2a). Instead, DNA methylation levels were lower in the high perceived stress group at SERT gene CpG 1 (Chr17: 30235932) when compared to the low perceived stress group (low = 3.24 ± 0.18; high = 2.85 ± 0.14, p = 0.0455) (Figure 2b).
Considering HSP, a significant increase in DNA methylation levels in students with high sensitivity compared to the medium sensitivity group was observed at DAT1 CpG 5 (Chr5: 1444694) (medium = 8.82 ± 0.70; high = 11.45 ± 0.67, p = 0.0326) (Figure 3a). No differences were observed at SERT DNA methylation levels considering the HPS values (Figure 3b).
Based on the HSP × PSS interaction (Figure 4a), significantly higher levels of methylation at DAT1 CpG 5 have been observed in the high cumulative risk compared to the medium cumulative risk group (medium = 8.30 ± 0.67; high = 11.54 ± 0.72, p = 0.0090) (Figure 4b). No differences among groups were observed for SERT DNA methylation levels (Figure 4c). The individual p values for each comparison are reported in Tables S2 and S3.
We correlated DAT1 DNA methylation levels in individual CpG sites, as well as in the average (Ave) of the 7 CpG under study with “low”, “medium”, and “high cumulative risk” groups (Figure 5a, b, and c, respectively), based on the HSP × PSS interaction. Methylation levels at CpG 2 (Chr5: 1444714), CpG 3 (Chr5: 1444711), and CpG 6 (Chr5: 1444632) were significantly correlated within the high-risk group (Figure 5c). Notably, within the low-risk groups (Figure 5a), the CpG 6 was inversely correlated to CpG 5 although not significantly, probably for the lower number of subjects in this group. Of note, we previously reported that CpG 5 was inversely correlated with CpGs 3 and 6 [66,67].

3.3. Genetic Analysis

We finally analyzed the repetition frequency of the 40 bp-VNTR located into the 3’UTR of the DAT1 gene and the SERT 5-HTTLPR polymorphism. The Chi-square test did not reveal a significant difference for the genotype as a function of the subjects’ HSP and PSS score classification (Tables S4 and S5), as well as for the interaction of the two parameters, HSP × PSS (Table S6). When we looked at the allele distribution, we observed instead a massive presence of the 9-repeat allele within the medium PSS group with respect to the other two groups (Chi-square: 18.17, p = 0.0058) (Table S5). No difference between the groups was observed when considering the 7-repeat, 8-repeat, and 10-repeat alleles.
We then considered correlating genotype distribution as a function of DNA methylation levels in the gene regions under study. In the DAT1 5’UTR considered for DNA methylation analysis, we observed higher DNA methylation levels at CpG 5 in the subjects with the 9/9 genotype (13.13 ± 1.58) compared to the 9/10 genotype (8.91 ± 0.40, p = 0.0332) (Figure 6a). The same analysis performed for the 5HTTLPR genotype as a function of SERT promoter region DNA methylation did not show any difference between the groups (Figure 6b).

3.4. miRNAs Analysis

We did not observe any difference in miR-132, miR-491, and miR-16-5p expression levels between all the subjects under study classified based on PSS and/or HSP scores (Figure 7a,b,d–h). Instead, we report a significant reduction in the expression of miR-135, targeting SERT, in subjects with high PSS with respect to the medium PSS group (medium: 1.67 ± 0.25; high: 1.12 ± 0.37, p = 0.0051, Kruskal–Wallis, Uncorrected Dunn’s test) (Figure 7c). When we considered the interaction of HSP × PSS parameters, an increase in the expression of miR-491, targeting DAT1, was observed in subjects with high scores (11.36 ± 3.33) when compared to those with medium scores (2.62 ± 1.15, p = 0.0196) (Figure 7j), while no differences between the groups under study were reported in the expression of the other miRNAs (Figure 7i,k,l). The individual p values for all the comparisons are reported in Table S7. We then correlated subjects’ miRNA expression considering the individual low, medium, and high PSS, HSP, and HSP × PSS scores. For both the PSS and HSP parameters, we observed a strong direct correlation between miR-135 expression and both miR-132 and miR-491, both of which are involved in DAT1 gene regulation. miR-135 showed a strong direct correlation with miR-132 considering the PSS (Spearman’s R = 0.438, p < 0.001) and the HSP (Spearman’s R = 0.438, p < 0.001), and the same correlation, also if weaker, was observed with miR-491 considering the PSS (Spearman’s R = 0.214, p = 0.0491) and the HSP parameters (Spearman’s R = 0.263, p = 0.0371) (Tables S8 and S9). Also considering the HSP × PSS interaction, again, we observed a direct relationship between miR-135 and miR-132 expression (Spearman’s R = 0.388, p < 0.001) (Table S10).

4. Discussion

The first main result of our study is that DAT1 gene regulation is affected in highly sensitive individuals, and this effect is emphasized in those reporting higher levels of stress. We report an increase in DNA methylation at one specific CpG site (number 5) at gene 5′UTR in highly sensitive individuals with higher PSS scores when compared to those less stressed. DNA methylation of the human DAT1 gene has been extensively investigated since 80% of its promoter is formed by GCs sequences and it has multiple CpG islands [68,69], and alterations in the epigenetic mark have been reported in different phenotypes, such as ADHD [70], alcohol dependence [71], mild Internet use [66], and nicotine dependence [72], showing at specific CpG sites both reductions as well as increases in methylation levels [72,73,74]. In particular, the transition from anti-correlation in low-risk subjects towards direct correlation in high-risk subjects was similarly found in our previous studies on internet addiction [66,67]. Of note, in the 5′-UTR analyzed, CpG site 5 together with CpG site 6 represents a CGCG-core motif, a stress response motif regulated by transcription factors members of calmodulin-binding transcription activators (CAMTAs) [75,76]. The higher levels of miR-491 in highly sensitive individuals further corroborate our data on DAT1 DNA methylation, both assuming the downregulation of the gene. Of note, miR-491 has already been reported to be involved in mental health [77].
Thus, both epigenetic mechanisms targeting DAT1 might be relevant as potential biomarkers to detect and confirm in highly sensitive subjects the presence of high perceived stress.
We also observed differences in DAT1 DNA methylation among the 3′-UTR VNTR genotypes. DNA methylation at CpG 5 is significantly higher in subjects with the 9/9 genotype, independently from the level of risk, compared to those with the 9/10 genotype. Moreover, HSP subjects with high levels of perceived stress carrying the 9/9 genotype have higher levels of DAT1 DNA methylation and higher expression of miR-491. Different VNTR genotypes affect the level of expression of DAT1 [78] and, consistent with our report, higher DAT1 expression was found in the presence of the 10-repeat allele [79]. Our data assume lower DAT availability, and this has been observed at the preclinical level to be evoked by early life stress [80] and at the clinical level in major depression [81,82,83,84].
Overall, our data on DAT1 transcriptional regulation could imply higher dopamine levels that might account for a mental health issue, since hyperdopaminergic activity characterizes several neuropsychiatric conditions.
We also support the possible role of SERT regulation in psychopathology [85,86,87]. In fact, SERT DNA methylation was reduced in subjects with higher levels of stress. Again, others already reported alterations in the epigenetic mark in individuals exposed to environmental stressful conditions [88], and in panic disorder patients [89], as well as in major depression associated with childhood adversities [90]. Moreover, we here report a potential role for miR-135, which might also be responsible for an increased SERT expression in subjects with higher stress levels. Of relevance, a previous study already observed the relevant role of miR-135 in chronic stress conditions associated with mood disorders [91]. Instead, we did not find any association of the 5-HTTLPR polymorphism with the different behavioral outcomes, in contrast with previous findings suggesting it is important in response to stress in female adolescents [92].
In conclusion, our data may be useful to suggest biomarkers that can bring attention to possible alarm bells for an alert condition. We hypothesize that integrating molecular data, genetics, and epigenetics with behavioral outcomes would help to identify subjects at greatest risk of developing mental health issues and thus provide possible resources for adaptive coping strategies to avoid maladaptive behaviors. In this context, the reversibility of epigenetic modifications is of great help as a possible preventive strategy through the manipulation of common environmental triggers such as diet and/or exercise. Of relevance, changes in environmental sensitivity are not only likely to predict maladjustment but can also be associated with better well-being when the environment is positive [93].
There are some limitations in our work that should be taken into consideration, like the low number of male participants. Future studies should investigate the feasibility of assessing sex differences in highly sensitive individuals. Moreover, in our analysis, we divided the population into different subgroups based on the PSS and HSP scores, and this enabled us to further stratify the analysis considering other sociodemographic variables.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biomedicines12092149/s1, Table S1: characteristic of the study sample and subdivision of the groups based on HSP and PSS scores; Table S2: DAT1 gene DNA methylation; Table S3: SERT gene DNA methylation; Table S4: genotypes and alleles distribution of DAT1 VNTR and SERT 5-HTTLPR between the groups based on subjects’ PSS score; Table S5: genotypes and alleles distribution of DAT1 VNTR and SERT 5-HTTLPR between the groups based on subjects’ HSP score; Table S6: genotypes and alleles distribution of DAT1 VNTR and SERT 5-HTTLPR between the groups based on subjects’ HSP × PSS score; Table S7: miRNAs expression; Table S8: miRNAs expression correlation considering the PSS scores; Table S9: miRNAs expression correlation considering the HSP scores; Table S10: miRNAs expression correlation considering the HSP × PSS scores.

Author Contributions

Conceptualization, C.D.; methodology, C.D., F.B., A.D.D. and L.C.; validation, C.D., L.C. and A.D.D.; formal analysis, F.B., A.P., E.A., L.C. and A.D.D.; investigation, F.B., A.P., E.A. and F.L.; resources, C.D. and R.P.; data curation, F.B., E.A., L.C. and M.P.; writing—original draft preparation, C.D., F.B., E.A., W.A. and M.P.; writing—review and editing, C.D., F.L., B.D., W.A., E.D. and R.P.; visualization, A.P., M.P. and F.B.; supervision, C.D.; funding acquisition, C.D. and R.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was partially funded by the European Union—Next Generation EU to C.D. Project Code: ECS00000041; Project CUP: C43C22000380007; Project Title: Innovation, digitalization, and sustainability for the diffused economy in Central Italy—VITALITY.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Psychology of the Department of Psychological, Health, and Territorial Sciences at G. D’Annunzio, University of Chieti-Pescara (identification code: 20026; date of approval: 19 February 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

Data will be made available on request.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Arnett, J.J. Emerging Adulthood: A Theory of Development from the Late Teens through the Twenties. Am. Psychol. 2000, 55, 469–480. [Google Scholar] [CrossRef] [PubMed]
  2. Barbayannis, G.; Franco, D.; Wong, S.; Galdamez, J.; Romeo, R.D.; Bauer, E.P. Differential Effects of Stress on Fear Learning and Activation of the Amygdala in Pre-Adolescent and Adult Male Rats. Neuroscience 2017, 360, 210–219. [Google Scholar] [CrossRef] [PubMed]
  3. Bosmans, G.; Young, J.F.; Hankin, B.L. NR3C1 Methylation as a Moderator of the Effects of Maternal Support and Stress on Insecure Attachment Development. Dev. Psychol. 2018, 54, 29–38. [Google Scholar] [CrossRef] [PubMed]
  4. Chiang, J.J.; Cole, S.W.; Bower, J.E.; Irwin, M.R.; Taylor, S.E.; Arevalo, J.; Fuligni, A.J. Daily Interpersonal Stress, Sleep Duration, and Gene Regulation during Late Adolescence. Psychoneuroendocrinology 2019, 103, 147–155. [Google Scholar] [CrossRef] [PubMed]
  5. Chubar, V.; Vaessen, T.; den Noortgate, W.V.; Lutin, E.; Bosmans, G.; Bekaert, B.; Van Leeuwen, K.; Calders, F.; Weyn, S.; Bijttebier, P.; et al. Mild Daily Stress, in Interaction with NR3C1 DNA Methylation Levels, Is Linked to Alterations in the HPA Axis and ANS Response to Acute Stress in Early Adolescents. Psychoneuroendocrinology 2023, 150, 106045. [Google Scholar] [CrossRef]
  6. Hogan, D.P.; Astone, N.M. The Transition to Adulthood. Annu. Rev. Sociol. 1986, 12, 109–130. [Google Scholar] [CrossRef]
  7. Lally, M.; Valentine-French, S. Lifespan Development: A Psychological Perspective; College of Lake County: Grayslake, IL, USA, 2019. [Google Scholar]
  8. Matud, M.P.; Díaz, A.; Bethencourt, J.M.; Ibáñez, I. Stress and Psychological Distress in Emerging Adulthood: A Gender Analysis. J. Clin. Med. 2020, 9, 2859. [Google Scholar] [CrossRef]
  9. Romeo, R.D. The Impact of Stress on the Structure of the Adolescent Brain: Implications for Adolescent Mental Health. Brain Res. 2017, 1654, 185–191. [Google Scholar] [CrossRef]
  10. Scales, P.C.; Benson, P.L.; Oesterle, S.; Hill, K.G.; Hawkins, J.D.; Pashak, T.J. The Dimensions of Successful Young Adult Development: A Conceptual and Measurement Framework. Appl. Dev. Sci. 2015, 20, 150–174. [Google Scholar] [CrossRef]
  11. Shanahan, M.J. Pathways to Adulthood in Changing Societies: Variability and Mechanisms in Life Course Perspective. Annu. Rev. Sociol. 2000, 26, 667–692. [Google Scholar] [CrossRef]
  12. Spear, L.P. The Adolescent Brain and Age-Related Behavioral Manifestations. Neurosci. Biobehav. Rev. 2000, 24, 417–463. [Google Scholar] [CrossRef] [PubMed]
  13. Pozos-Radillo, B.E.; Preciado-Serrano, M.d.L.; Acosta-Fernández, M.; Aguilera-Velasco, M.d.l.Á.; Delgado-García, D.D. Academic Stress as a Predictor of Chronic Stress in University Students. Psicol. Educ. 2014, 20, 47–52. [Google Scholar] [CrossRef]
  14. Cannito, L.; Annunzi, E.; Viganò, C.; Dell’Osso, B.; Vismara, M.; Sacco, P.L.; Palumbo, R.; D’Addario, C. The Role of Stress and Cognitive Absorption in Predicting Social Network Addiction. Brain Sci. 2022, 12, 643. [Google Scholar] [CrossRef] [PubMed]
  15. Karyotaki, E.; Cuijpers, P.; Albor, Y.; Alonso, J.; Auerbach, R.P.; Bantjes, J.; Bruffaerts, R.; Ebert, D.D.; Hasking, P.; Kiekens, G.; et al. Sources of Stress and Their Associations with Mental Disorders among College Students: Results of the World Health Organization World Mental Health Surveys International College Student Initiative. Front. Psychol. 2020, 11, 1759. [Google Scholar] [CrossRef]
  16. Liu, C.H.; Stevens, C.; Wong, S.H.M.; Yasui, M.; Chen, J.A. The Prevalence and Predictors of Mental Health Diagnoses and Suicide among U.S. College Students: Implications for Addressing Disparities in Service Use. Depress. Anxiety 2019, 36, 8–17. [Google Scholar] [CrossRef] [PubMed]
  17. Pedrelli, P.; Nyer, M.; Yeung, A.; Zulauf, C.; Wilens, T. College Students: Mental Health Problems and Treatment Considerations. Acad. Psychiatry 2015, 39, 503–511. [Google Scholar] [CrossRef]
  18. Blanco, C.; Okuda, M.; Wright, C.; Hasin, D.S.; Grant, B.F.; Liu, S.-M.; Olfson, M. Mental Health of College Students and Their Non-College-Attending Peers: Results from the National Epidemiologic Study on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2008, 65, 1429–1437. [Google Scholar] [CrossRef]
  19. Reddy, K.J.; Menon, K.R.; Thattil, A. Academic Stress and Its Sources Among University Students. Biomed. Pharmacol. J. 2018, 11, 531–537. [Google Scholar]
  20. Saleh, A.; Potter, G.G.; McQuoid, D.R.; Boyd, B.; Turner, R.; MacFall, J.R.; Taylor, W.D. Effects of Early Life Stress on Depression, Cognitive Performance and Brain Morphology. Psychol. Med. 2017, 47, 171–181. [Google Scholar] [CrossRef]
  21. Lee, S.; Lee, J.; Yoo, S.; Suh, S.; Chung, S.; Lee, S.A. The Psychometric Properties of the Stress and Anxiety to Viral Epidemics-6 Items: A Test in the U.S. General Population. Front. Psychiatry 2021, 12, 746244. [Google Scholar] [CrossRef]
  22. Natalia, J.R.; Bernathsius, J. Highly Sensitive Person dan Dampaknya terhadap Kesehatan Mental. J. Keperawatan Jiwa 2019, 7, 317–322. [Google Scholar] [CrossRef]
  23. Pluess, M.; Lionetti, F.; Aron, E.N.; Aron, A. People Differ in Their Sensitivity to the Environment: An Integrated Theory, Measurement and Empirical Evidence. J. Res. Personal. 2023, 104, 104377. [Google Scholar] [CrossRef]
  24. Aron, E.N.; Aron, A. Sensory-Processing Sensitivity and Its Relation to Introversion and Emotionality. J. Personal. Soc. Psychol. 1997, 73, 345–368. [Google Scholar] [CrossRef] [PubMed]
  25. Iimura, S.; Yano, K.; Ishii, Y. Environmental Sensitivity in Adults: Psychometric Properties of the Japanese Version of the Highly Sensitive Person Scale 10-Item Version. J. Personal. Assess. 2023, 105, 87–99. [Google Scholar] [CrossRef] [PubMed]
  26. Pluess, M. Individual Differences in Environmental Sensitivity. Child Dev. Perspect. 2015, 9, 138–143. [Google Scholar] [CrossRef]
  27. Benham, G. The Highly Sensitive Person: Stress and Physical Symptom Reports. Personal. Individ. Differ. 2006, 40, 1433–1440. [Google Scholar] [CrossRef]
  28. Greven, C.U.; Lionetti, F.; Booth, C.; Aron, E.N.; Fox, E.; Schendan, H.E.; Pluess, M.; Bruining, H.; Acevedo, B.; Bijttebier, P.; et al. Sensory Processing Sensitivity in the Context of Environmental Sensitivity: A Critical Review and Development of Research Agenda. Neurosci. Biobehav. Rev. 2019, 98, 287–305. [Google Scholar] [CrossRef]
  29. Bakermans-Kranenburg, M.J.; Ijzendoorn, M.H. van Differential Susceptibility to Rearing Environment Depending on Dopamine-Related Genes: New Evidence and a Meta-Analysis. Dev. Psychopathol. 2011, 23, 39–52. [Google Scholar] [CrossRef]
  30. Chen, C.; Chen, C.; Moyzis, R.; Stern, H.; He, Q.; Li, H.; Li, J.; Zhu, B.; Dong, Q. Contributions of Dopamine-Related Genes and Environmental Factors to Highly Sensitive Personality: A Multi-Step Neuronal System-Level Approach. PLoS ONE 2011, 6, e21636. [Google Scholar] [CrossRef]
  31. Homberg, J.R.; Kyzar, E.J.; Nguyen, M.; Norton, W.H.; Pittman, J.; Poudel, M.K.; Gaikwad, S.; Nakamura, S.; Koshiba, M.; Yamanouchi, H.; et al. Understanding Autism and Other Neurodevelopmental Disorders through Experimental Translational Neurobehavioral Models. Neurosci. Biobehav. Rev. 2016, 65, 292–312. [Google Scholar] [CrossRef]
  32. Schinka, J.A.; Busch, R.M.; Robichaux-Keene, N. A Meta-Analysis of the Association between the Serotonin Transporter Gene Polymorphism (5-HTTLPR) and Trait Anxiety. Mol. Psychiatry 2004, 9, 197–202. [Google Scholar] [CrossRef] [PubMed]
  33. Minelli, A.; Bonvicini, C.; Scassellati, C.; Sartori, R.; Gennarelli, M. The Influence of Psychiatric Screening in Healthy Populations Selection: A New Study and Meta-Analysis of Functional 5-HTTLPR and Rs25531 Polymorphisms and Anxiety-Related Personality Traits. BMC Psychiatry 2011, 11, 50. [Google Scholar] [CrossRef] [PubMed]
  34. Delli Colli, C.; Borgi, M.; Poggini, S.; Chiarotti, F.; Cirulli, F.; Penninx, B.W.J.H.; Benedetti, F.; Vai, B.; Branchi, I. Time Moderates the Interplay between 5-HTTLPR and Stress on Depression Risk: Gene x Environment Interaction as a Dynamic Process. Transl. Psychiatry 2022, 12, 1–12. [Google Scholar] [CrossRef] [PubMed]
  35. Miño, V.; San Martín, C.; Alfaro, F.; Miguez, G.; Laborda, M.A.; Bacigalupo, F.; Quezada-Scholz, V. Meta-Analysis of the Effect of 5HTTLPR Polymorphism in Fear Learning. Learn. Motiv. 2023, 82, 101889. [Google Scholar] [CrossRef]
  36. Lesch, K.-P.; Bengel, D.; Heils, A.; Sabol, S.Z.; Greenberg, B.D.; Petri, S.; Benjamin, J.; Müller, C.R.; Hamer, D.H.; Murphy, D.L. Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region. Science 1996, 274, 1527–1531. [Google Scholar] [CrossRef]
  37. Gonda, X.; Fountoulakis, K.N.; Juhasz, G.; Rihmer, Z.; Lazary, J.; Laszik, A.; Akiskal, H.S.; Bagdy, G. Association of the s Allele of the 5-HTTLPR with Neuroticism-Related Traits and Temperaments in a Psychiatrically Healthy Population. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259, 106–113. [Google Scholar] [CrossRef]
  38. Ming, Q.; Zhang, Y.; Yi, J.; Wang, X.; Zhu, X.; Yao, S. Serotonin Transporter Gene Polymorphism (5-HTTLPR) L Allele Interacts with Stress to Increase Anxiety Symptoms in Chinese Adolescents: A Multiwave Longitudinal Study. BMC Psychiatry 2015, 15, 248. [Google Scholar] [CrossRef]
  39. Zuschlag, Z.D.; Compean, E.; Nietert, P.; Lauzon, S.; Hamner, M.; Wang, Z. Dopamine Transporter (DAT1) Gene in Combat Veterans with PTSD: A Case-Control Study. Psychiatry Res. 2021, 298, 113801. [Google Scholar] [CrossRef]
  40. Gadow, K.D.; Roohi, J.; DeVincent, C.J.; Hatchwell, E. Association of ADHD, Tics, and Anxiety with Dopamine Transporter (DAT1) Genotype in Autism Spectrum Disorder. J. Child Psychol. Psychiatry 2008, 49, 1331–1338. [Google Scholar] [CrossRef]
  41. Dreher, J.-C.; Kohn, P.; Kolachana, B.; Weinberger, D.R.; Berman, K.F. Variation in Dopamine Genes Influences Responsivity of the Human Reward System. Proc. Natl. Acad. Sci. USA 2009, 106, 617–622. [Google Scholar] [CrossRef]
  42. Plomin, R.; Haworth, C.M.A.; Davis, O.S.P. Common Disorders Are Quantitative Traits. Nat. Rev. Genet. 2009, 10, 872–878. [Google Scholar] [CrossRef] [PubMed]
  43. Keers, R.; Coleman, J.R.I.; Lester, K.J.; Roberts, S.; Breen, G.; Thastum, M.; Bögels, S.; Schneider, S.; Heiervang, E.; Meiser-Stedman, R.; et al. A Genome-Wide Test of the Differential Susceptibility Hypothesis Reveals a Genetic Predictor of Differential Response to Psychological Treatments for Child Anxiety Disorders. Psychother. Psychosom. 2016, 85, 146–158. [Google Scholar] [CrossRef]
  44. McGuffin, P.; Rijsdijk, F.; Andrew, M.; Sham, P.; Katz, R.; Cardno, A. The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression. Arch. Gen. Psychiatry 2003, 60, 497. [Google Scholar] [CrossRef] [PubMed]
  45. Caspi, A.; McClay, J.; Moffitt, T.E.; Mill, J.; Martin, J.; Craig, I.W.; Taylor, A.; Poulton, R. Role of Genotype in the Cycle of Violence in Maltreated Children. Science 2002, 297, 851–854. [Google Scholar] [CrossRef] [PubMed]
  46. Caspi, A.; Sugden, K.; Moffitt, T.E.; Taylor, A.; Craig, I.W.; Harrington, H.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene. Science 2003, 301, 386–389. [Google Scholar] [CrossRef]
  47. Bellia, F.; Vismara, M.; Annunzi, E.; Cifani, C.; Benatti, B.; Dell’Osso, B.; D’Addario, C. Genetic and Epigenetic Architecture of Obsessive-Compulsive Disorder: In Search of Possible Diagnostic and Prognostic Biomarkers. J. Psychiatr. Res. 2021, 137, 554–571. [Google Scholar] [CrossRef]
  48. Isles, A.R. Neural and Behavioral Epigenetics; What It Is, and What Is Hype. Genes Brain Behav. 2015, 14, 64–72. [Google Scholar] [CrossRef]
  49. Schiele, M.A.; Domschke, K. Epigenetics at the Crossroads between Genes, Environment and Resilience in Anxiety Disorders. Genes Brain Behav. 2018, 17, e12423. [Google Scholar] [CrossRef]
  50. Lionetti, F.; Dumpfrey, R.S.C.; Richetin, J.; Fasolo, M.; Nocentini, A.; Penolazzi, B.; Pluess, M.; Santona, A.; Spinelli, M.; Preti, E. Is Environmental Sensitivity a Unique Trait? A Multi-Sample Study on the Association between Sensitivity, Personality, and Psychological Adjustment. Personal. Individ. Differ. 2024, 217, 112463. [Google Scholar] [CrossRef]
  51. D’Addario, C.; Macellaro, M.; Bellia, F.; Benatti, B.; Annunzi, E.; Palumbo, R.; Conti, D.; Fasciana, F.; Vismara, M.; Varinelli, A.; et al. In Search for Biomarkers in Obsessive-Compulsive Disorder: New Evidence on Saliva as a Practical Source of DNA to Assess Epigenetic Regulation. Curr. Med. Chem. 2021, 29, 5782–5791. [Google Scholar] [CrossRef]
  52. Han, Y.; Jia, L.; Zheng, Y.; Li, W. Salivary Exosomes: Emerging Roles in Systemic Disease. Int. J. Biol. Sci. 2018, 14, 633–643. [Google Scholar] [CrossRef] [PubMed]
  53. Gallo, A.; Tandon, M.; Alevizos, I.; Illei, G.G. The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes. PLoS ONE 2012, 7, e30679. [Google Scholar] [CrossRef]
  54. Braun, P.R.; Han, S.; Hing, B.; Nagahama, Y.; Gaul, L.N.; Heinzman, J.T.; Grossbach, A.J.; Close, L.; Dlouhy, B.J.; Howard, M.A.; et al. Genome-Wide DNA Methylation Comparison between Live Human Brain and Peripheral Tissues within Individuals. Transl. Psychiatry 2019, 9, 47. [Google Scholar] [CrossRef] [PubMed]
  55. D’Addario, C.; Pucci, M.; Bellia, F.; Girella, A.; Sabatucci, A.; Fanti, F.; Vismara, M.; Benatti, B.; Ferrara, L.; Fasciana, F.; et al. Regulation of Oxytocin Receptor Gene Expression in Obsessive–Compulsive Disorder: A Possible Role for the Microbiota-Host Epigenetic Axis. Clin. Epigenetics 2022, 14, 47. [Google Scholar] [CrossRef] [PubMed]
  56. Smolewska, K.A.; McCabe, S.B.; Woody, E.Z. A Psychometric Evaluation of the Highly Sensitive Person Scale: The Components of Sensory-Processing Sensitivity and Their Relation to the BIS/BAS and “Big Five”. Personal. Individ. Differ. 2006, 40, 1269–1279. [Google Scholar] [CrossRef]
  57. Lionetti, F.; Aron, A.; Aron, E.N.; Burns, G.L.; Jagiellowicz, J.; Pluess, M. Dandelions, Tulips and Orchids: Evidence for the Existence of Low-Sensitive, Medium-Sensitive and High-Sensitive Individuals. Transl. Psychiatry 2018, 8, 1–11. [Google Scholar] [CrossRef]
  58. Cohen, S.; Kamarck, T.; Mermelstein, R. A Global Measure of Perceived Stress. J. Health Soc. Behav. 1983, 24, 385–396. [Google Scholar] [CrossRef]
  59. Diotaiuti, P.; Valente, G.; Mancone, S. Validation Study of the Italian Version of Temporal Focus Scale: Psychometric Properties and Convergent Validity. BMC Psychol. 2021, 9, 19. [Google Scholar] [CrossRef]
  60. Goode, M.R.; Cheong, S.Y.; Li, N.; Ray, W.C.; Bartlett, C.W. Collection and Extraction of Saliva DNA for next Generation Sequencing. J. Vis. Exp. 2014, 51697. [Google Scholar] [CrossRef]
  61. Anzani, S.; Cannito, L.; Bellia, F.; Di Domenico, A.; Dell’Osso, B.; Palumbo, R.; D’Addario, C. OXTR Gene DNA Methylation Levels Are Associated with Discounting Behavior with Untrustworthy Proposers. Brain Sci. 2022, 12, 98. [Google Scholar] [CrossRef]
  62. Dejeux, E.; Abdalaoui, H.E.; Gut, I.G.; Tost, J. Identification and Quantification of Differentially Methylated Loci by the PyrosequencingTM Technology. In DNA Methylation: Methods and Protocols; Tost, J., Ed.; Humana Press: Totowa, NJ, USA, 2009; pp. 189–205. ISBN 978-1-59745-522-0. [Google Scholar]
  63. Chen, Y.; Wang, X. miRDB: An Online Database for Prediction of Functional microRNA Targets. Nucleic Acids Res. 2020, 48, D127–D131. [Google Scholar] [CrossRef] [PubMed]
  64. Sookoian, S.; Gemma, C.; García, S.I.; Gianotti, T.F.; Dieuzeide, G.; Roussos, A.; Tonietti, M.; Trifone, L.; Kanevsky, D.; González, C.D.; et al. Short Allele of Serotonin Transporter Gene Promoter Is a Risk Factor for Obesity in Adolescents. Obesity 2007, 15, 271–276. [Google Scholar] [CrossRef] [PubMed]
  65. Shinohara, M.; Mizushima, H.; Hirano, M.; Shioe, K.; Nakazawa, M.; Hiejima, Y.; Ono, Y.; Kanba, S. Eating Disorders with Binge-Eating Behaviour Are Associated with the s Allele of the 3’-UTR VNTR Polymorphism of the Dopamine Transporter Gene. J. Psychiatry Neurosci. 2004, 29, 134–137. [Google Scholar] [PubMed]
  66. Annunzi, E.; Cannito, L.; Bellia, F.; Mercante, F.; Vismara, M.; Benatti, B.; Di Domenico, A.; Palumbo, R.; Adriani, W.; Dell’Osso, B.; et al. Mild Internet Use Is Associated with Epigenetic Alterations of Key Neurotransmission Genes in Salivary DNA of Young University Students. Sci. Rep. 2023, 13, 22192. [Google Scholar] [CrossRef]
  67. Nardi, L.D.; Carpentieri, V.; Pascale, E.; Pucci, M.; D’Addario, C.; Cerniglia, L.; Adriani, W.; Cimino, S. Involvement of DAT1 Gene on Internet Addiction: Cross-Correlations of Methylation Levels in 5′-UTR and 3’-UTR Genotypes, Interact with Impulsivity and Attachment-Driven Quality of Relationships. Int. J. Environ. Res. Public Health 2020, 17, 7956. [Google Scholar] [CrossRef]
  68. Bannon, M.J.; Michelhaugh, S.K.; Wang, J.; Sacchetti, P. The Human Dopamine Transporter Gene: Gene Organization, Transcriptional Regulation, and Potential Involvement in Neuropsychiatric Disorders. Eur. Neuropsychopharmacol. 2001, 11, 449–455. [Google Scholar] [CrossRef]
  69. Shumay, E.; Fowler, J.S.; Volkow, N.D. Genomic Features of the Human Dopamine Transporter Gene and Its Potential Epigenetic States: Implications for Phenotypic Diversity. PLoS ONE 2010, 5, e11067. [Google Scholar] [CrossRef]
  70. Adriani, W.; Romano, E.; Pucci, M.; Pascale, E.; Cerniglia, L.; Cimino, S.; Tambelli, R.; Curatolo, P.; Granstrem, O.; Maccarrone, M.; et al. Potential for Diagnosis versus Therapy Monitoring of Attention Deficit Hyperactivity Disorder: A New Epigenetic Biomarker Interacting with Both Genotype and Auto-Immunity. Eur. Child Adolesc. Psychiatry 2018, 27, 241–252. [Google Scholar] [CrossRef]
  71. Wiers, C.E.; Shumay, E.; Volkow, N.D.; Frieling, H.; Kotsiari, A.; Lindenmeyer, J.; Walter, H.; Bermpohl, F. Effects of Depressive Symptoms and Peripheral DAT Methylation on Neural Reactivity to Alcohol Cues in Alcoholism. Transl. Psychiatry 2015, 5, e648. [Google Scholar] [CrossRef]
  72. Chmielowiec, K.; Chmielowiec, J.; Masiak, J.; Strońska-Pluta, A.; Lachowicz, M.; Boroń, A.; Larysz, D.; Dzitkowska-Zabielska, M.; Cięszczyk, P.; Grzywacz, A. DNA Methylation of the Dopamine Transporter DAT1 Gene—Bliss Seekers in the Light of Epigenetics. Int. J. Mol. Sci. 2023, 24, 5265. [Google Scholar] [CrossRef]
  73. Hillemacher, T.; Frieling, H.; Hartl, T.; Wilhelm, J.; Kornhuber, J.; Bleich, S. Promoter Specific Methylation of the Dopamine Transporter Gene Is Altered in Alcohol Dependence and Associated with Craving. J. Psychiatr. Res. 2009, 43, 388–392. [Google Scholar] [CrossRef] [PubMed]
  74. Rubino, A.; D’Addario, C.; Di Bartolomeo, M.; Michele Salamone, E.; Locuratolo, N.; Fattapposta, F.; Vanacore, N.; Pascale, E. DNA Methylation of the 5′-UTR DAT1 Gene in Parkinson’s Disease Patients. Acta Neurol. Scand. 2020, 142, 275–280. [Google Scholar] [CrossRef] [PubMed]
  75. Mollet, I.G.; Malm, H.A.; Wendt, A.; Orho-Melander, M.; Eliasson, L. Integrator of Stress Responses Calmodulin Binding Transcription Activator 1 (Camta1) Regulates miR-212/miR-132 Expression and Insulin Secretion. J. Biol. Chem. 2016, 291, 18440–18452. [Google Scholar] [CrossRef] [PubMed]
  76. Shen, C.; Yang, Y.; Du, L.; Wang, H. Calmodulin-Binding Transcription Activators and Perspectives for Applications in Biotechnology. Appl. Microbiol. Biotechnol. 2015, 99, 10379–10385. [Google Scholar] [CrossRef] [PubMed]
  77. Serafini, G.; Pompili, M.; Hansen, K.F.; Obrietan, K.; Dwivedi, Y.; Shomron, N.; Girardi, P. The Involvement of microRNAs in Major Depression, Suicidal Behavior, and Related Disorders: A Focus on miR-185 and miR-491-3p. Cell. Mol. Neurobiol. 2014, 34, 17–30. [Google Scholar] [CrossRef]
  78. Glavina Jelaš, I.; Dević, I.; Karlović, D. Cloninger’s Temperament and Character Dimensions and Dopaminergic Genes: DAT1 VNTR and COMT Val158Met Polymorphisms. Psychiatr. Danub. 2018, 30, 47–56. [Google Scholar] [CrossRef]
  79. Fuke, S.; Suo, S.; Takahashi, N.; Koike, H.; Sasagawa, N.; Ishiura, S. The VNTR Polymorphism of the Human Dopamine Transporter (DAT1) Gene Affects Gene Expression. Pharmacogenom. J. 2001, 1, 152–156. [Google Scholar] [CrossRef]
  80. Catale, C.; Lo Iacono, L.; Martini, A.; Heil, C.; Guatteo, E.; Mercuri, N.B.; Viscomi, M.T.; Palacios, D.; Carola, V. Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes That Are Prevented by Minocycline. Mol. Neurobiol. 2022, 59, 3913–3932. [Google Scholar] [CrossRef]
  81. Dubol, M.; Trichard, C.; Leroy, C.; Granger, B.; Tzavara, E.T.; Martinot, J.-L.; Artiges, E. Lower Midbrain Dopamine Transporter Availability in Depressed Patients: Report from High-Resolution PET Imaging. J. Affect. Disord. 2020, 262, 273–277. [Google Scholar] [CrossRef]
  82. Meyer, J.H.; Krüger, S.; Wilson, A.A.; Christensen, B.K.; Goulding, V.S.; Schaffer, A.; Minifie, C.; Houle, S.; Hussey, D.; Kennedy, S.H. Lower Dopamine Transporter Binding Potential in Striatum during Depression. Neuroreport 2001, 12, 4121–4125. [Google Scholar] [CrossRef]
  83. Moriya, H.; Tiger, M.; Tateno, A.; Sakayori, T.; Masuoka, T.; Kim, W.; Arakawa, R.; Okubo, Y. Low Dopamine Transporter Binding in the Nucleus Accumbens in Geriatric Patients with Severe Depression. Psychiatry Clin. Neurosci. 2020, 74, 424–430. [Google Scholar] [CrossRef] [PubMed]
  84. Pizzagalli, D.A.; Berretta, S.; Wooten, D.; Goer, F.; Pilobello, K.T.; Kumar, P.; Murray, L.; Beltzer, M.; Boyer-Boiteau, A.; Alpert, N.; et al. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence. JAMA Psychiatry 2019, 76, 854–861. [Google Scholar] [CrossRef] [PubMed]
  85. Beach, S.R.H.; Brody, G.H.; Todorov, A.A.; Gunter, T.D.; Philibert, R.A. Methylation at SLC6A4 Is Linked to Family History of Child Abuse: An Examination of the Iowa Adoptee Sample. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2010, 153B, 710–713. [Google Scholar] [CrossRef] [PubMed]
  86. Olsson, C.A.; Foley, D.L.; Parkinson-Bates, M.; Byrnes, G.; McKenzie, M.; Patton, G.C.; Morley, R.; Anney, R.J.L.; Craig, J.M.; Saffery, R. Prospects for Epigenetic Research within Cohort Studies of Psychological Disorder: A Pilot Investigation of a Peripheral Cell Marker of Epigenetic Risk for Depression. Biol. Psychol. 2010, 83, 159–165. [Google Scholar] [CrossRef]
  87. Philibert, R.A.; Sandhu, H.; Hollenbeck, N.; Gunter, T.; Adams, W.; Madan, A. The Relationship of 5HTT (SLC6A4) Methylation and Genotype on mRNA Expression and Liability to Major Depression and Alcohol Dependence in Subjects from the Iowa Adoption Studies. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2008, 147B, 543–549. [Google Scholar] [CrossRef]
  88. Alasaari, J.S.; Lagus, M.; Ollila, H.M.; Toivola, A.; Kivimäki, M.; Vahtera, J.; Kronholm, E.; Härmä, M.; Puttonen, S.; Paunio, T. Environmental Stress Affects DNA Methylation of a CpG Rich Promoter Region of Serotonin Transporter Gene in a Nurse Cohort. PLoS ONE 2012, 7, e45813. [Google Scholar] [CrossRef]
  89. Leibold, N.K.; Weidner, M.T.; Ziegler, C.; Ortega, G.; Domschke, K.; Lesch, K.P.; Van Den Hove, D.L.; Schruers, K.R. DNA Methylation in the 5-HTT Regulatory Region Is Associated with CO2-Induced Fear in Panic Disorder Patients. Eur. Neuropsychopharmacol. 2020, 36, 154–159. [Google Scholar] [CrossRef]
  90. Kang, H.-J.; Kim, J.-M.; Stewart, R.; Kim, S.-Y.; Bae, K.-Y.; Kim, S.-W.; Shin, I.-S.; Shin, M.-G.; Yoon, J.-S. Association of SLC6A4 Methylation with Early Adversity, Characteristics and Outcomes in Depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 44, 23–28. [Google Scholar] [CrossRef]
  91. Issler, O.; Haramati, S.; Paul, E.D.; Maeno, H.; Navon, I.; Zwang, R.; Gil, S.; Mayberg, H.S.; Dunlop, B.W.; Menke, A.; et al. MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity. Neuron 2014, 83, 344–360. [Google Scholar] [CrossRef]
  92. Gotlib, I.H.; Joormann, J.; Minor, K.L.; Hallmayer, J. HPA Axis Reactivity: A Mechanism Underlying the Associations Among 5-HTTLPR, Stress, and Depression. Biol. Psychiatry 2008, 63, 847–851. [Google Scholar] [CrossRef]
  93. Belsky, J.; Bakermans-Kranenburg, M.J.; van IJzendoorn, M.H. For Better and For Worse: Differential Susceptibility to Environmental Influences. Curr. Dir. Psychol. Sci. 2007, 16, 300–304. [Google Scholar] [CrossRef]
Figure 1. Schematic representation of the human DAT1 (a) and SERT (b) genes. Boxes represent the exons, with the translated part filled in dark gray, ATG is also indicated. In the lower part of each panel, the CpG islands are reported, which are highlighted as the CpG sites under study as well as DAT1 VNTR and SERT HTTLPR.
Figure 1. Schematic representation of the human DAT1 (a) and SERT (b) genes. Boxes represent the exons, with the translated part filled in dark gray, ATG is also indicated. In the lower part of each panel, the CpG islands are reported, which are highlighted as the CpG sites under study as well as DAT1 VNTR and SERT HTTLPR.
Biomedicines 12 02149 g001
Figure 2. DNA methylation levels at DAT1 (a) and SERT (b) CpG islands in saliva samples of young adults with PSS<13, 14<PSS<26, and PSS>27, represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (* p < 0.05).
Figure 2. DNA methylation levels at DAT1 (a) and SERT (b) CpG islands in saliva samples of young adults with PSS<13, 14<PSS<26, and PSS>27, represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (* p < 0.05).
Biomedicines 12 02149 g002
Figure 3. DNA methylation levels at DAT1 (a) and SERT (b) CpG islands in saliva samples of young adults with HSP<4, 4<HSP<4.5, and HSP>4.5, represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (* p < 0.05).
Figure 3. DNA methylation levels at DAT1 (a) and SERT (b) CpG islands in saliva samples of young adults with HSP<4, 4<HSP<4.5, and HSP>4.5, represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (* p < 0.05).
Biomedicines 12 02149 g003
Figure 4. Subjects’ distribution considering the correlation between the PSS (Y axis) and the total HSP scores (X axis), determining 3 groups with a “low” (green circles), “medium” (yellow circles), and “high” cumulative risk (red circles) based on the interaction of the two parameters (a). DNA methylation levels at DAT1 (b) and SERT (c) genes in saliva samples of young adults represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (** p < 0.01).
Figure 4. Subjects’ distribution considering the correlation between the PSS (Y axis) and the total HSP scores (X axis), determining 3 groups with a “low” (green circles), “medium” (yellow circles), and “high” cumulative risk (red circles) based on the interaction of the two parameters (a). DNA methylation levels at DAT1 (b) and SERT (c) genes in saliva samples of young adults represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (** p < 0.01).
Biomedicines 12 02149 g004
Figure 5. Heat maps representing the correlation analysis between DNA methylation levels at each CpG site of DAT1 gene. Cells filled from green to red gradient (lower part) represent Spearman’s r; cells filled from yellow to red gradient (upper part) represent p values (empty cells represent p values greater than 0.05). Subjects under study are divided considering the correlation between the PSS and the total HSP scores, identifying a low (a), medium (b), and high (c) cumulative risk.
Figure 5. Heat maps representing the correlation analysis between DNA methylation levels at each CpG site of DAT1 gene. Cells filled from green to red gradient (lower part) represent Spearman’s r; cells filled from yellow to red gradient (upper part) represent p values (empty cells represent p values greater than 0.05). Subjects under study are divided considering the correlation between the PSS and the total HSP scores, identifying a low (a), medium (b), and high (c) cumulative risk.
Biomedicines 12 02149 g005
Figure 6. DNA methylation levels at DAT1 (a) and SERT (b) CpG islands in saliva samples of young adults divided for their genotype at DAT1 VNTR (a) and SERT 5-HTTLPR (b). Subjects are represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (* p < 0.05).
Figure 6. DNA methylation levels at DAT1 (a) and SERT (b) CpG islands in saliva samples of young adults divided for their genotype at DAT1 VNTR (a) and SERT 5-HTTLPR (b). Subjects are represented as scattered dot plots (mean ± SEM, of each group) for the individual CpG sites and the average (Ave) of the CpG sites included in the study. Significant differences are indicated (* p < 0.05).
Biomedicines 12 02149 g006
Figure 7. Expression levels of miR-132 (a,e,i), miR-491 (b,f,j), miR-135 (c,g,k), and miR-16-5p (d,h,l) in subjects reporting low, medium, or high score of PSS, HSP, and HSP × PSS. Significant differences are indicated (* p < 0.05; ** p < 0.01).
Figure 7. Expression levels of miR-132 (a,e,i), miR-491 (b,f,j), miR-135 (c,g,k), and miR-16-5p (d,h,l) in subjects reporting low, medium, or high score of PSS, HSP, and HSP × PSS. Significant differences are indicated (* p < 0.05; ** p < 0.01).
Biomedicines 12 02149 g007
Table 1. Sequences considered for DNA methylation analysis. GeneGlobe Identification numbers refer to the assay designed for the analysis. Detailed genomic locations are reported.
Table 1. Sequences considered for DNA methylation analysis. GeneGlobe Identification numbers refer to the assay designed for the analysis. Detailed genomic locations are reported.
GeneGeneGlobe IDSequence AnalysedCpG SitesGenomic Location
DAT1PM00022064GCGGCGGCGGCTTGCCRGAGACTCGCGAGCTCCGC6Chr5, bp 1444718-1444679
SERTPM00065625CCCCGACACACACACACGCTCGCAGGGAGGAGCGGAGCGCGGA6Chr17, bp 30235935-30235893
Table 2. Sequences considered for miRNA expression analysis. GeneGlobe Identification numbers refer to the assay designed for the analysis. miRBase accession codes and mature miRNA sequences are reported.
Table 2. Sequences considered for miRNA expression analysis. GeneGlobe Identification numbers refer to the assay designed for the analysis. miRBase accession codes and mature miRNA sequences are reported.
miRNAGeneGlobe IDmiRbase AccessionMature miRNA Sequence
hsa-miR-26a-5pYP00206023MIMAT0000082UUCAAGUAAUCCAGGAUAGGCU
U6 snRNAYP02119464U6snRNA
hsa-miR-132-3pYP00206035MIMAT0000426UAACAGUCUACAGCCAUGGUCG
hsa-miR-491-5pYP00204695MIMAT0002807AGUGGGGAACCCUUCCAUGAGG
hsa-miR-16-5pYP00205702MIMAT0000069UAGCAGCACGUAAAUAUUGGCG
hsa-miR-135YP00204762MIMAT0000428UAUGGCUUUUUAUUCCUAUGUGA
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bellia, F.; Piccinini, A.; Annunzi, E.; Cannito, L.; Lionetti, F.; Dell’Osso, B.; Adriani, W.; Dainese, E.; Di Domenico, A.; Pucci, M.; et al. Dopamine and Serotonin Transporter Genes Regulation in Highly Sensitive Individuals during Stressful Conditions: A Focus on Genetics and Epigenetics. Biomedicines 2024, 12, 2149. https://doi.org/10.3390/biomedicines12092149

AMA Style

Bellia F, Piccinini A, Annunzi E, Cannito L, Lionetti F, Dell’Osso B, Adriani W, Dainese E, Di Domenico A, Pucci M, et al. Dopamine and Serotonin Transporter Genes Regulation in Highly Sensitive Individuals during Stressful Conditions: A Focus on Genetics and Epigenetics. Biomedicines. 2024; 12(9):2149. https://doi.org/10.3390/biomedicines12092149

Chicago/Turabian Style

Bellia, Fabio, Alessandro Piccinini, Eugenia Annunzi, Loreta Cannito, Francesca Lionetti, Bernardo Dell’Osso, Walter Adriani, Enrico Dainese, Alberto Di Domenico, Mariangela Pucci, and et al. 2024. "Dopamine and Serotonin Transporter Genes Regulation in Highly Sensitive Individuals during Stressful Conditions: A Focus on Genetics and Epigenetics" Biomedicines 12, no. 9: 2149. https://doi.org/10.3390/biomedicines12092149

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop